Quick Answer
RAPID MICRO BIOSYSTEMS, INC. reported Total Revenue of $33.59 million for fiscal year 2025.
RAPID MICRO BIOSYSTEMS, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $33.59M +19.7% |
$28.05M +24.6% |
$22.52M +31.4% |
$17.13M -26.3% |
$23.23M +44.5% |
$16.08M |
| Revenue (ASC 606) | $33.59M +19.7% |
$28.05M +24.6% |
$22.52M +31.4% |
$17.13M -26.3% |
$23.23M +44.5% |
$16.08M |
| Net Income | -$47.12M -0.5% |
-$46.89M +10.6% |
-$52.47M +13.7% |
-$60.81M +17.3% |
-$73.52M -98.3% |
-$37.08M |
| Diluted EPS | -$1.05 +2.8% |
-$1.08 +11.5% |
-$1.22 +14.7% |
-$1.43 +63.7% |
-$3.94 +96.9% |
-$126.11 |
| Total Assets | $74.85M -23.8% |
$98.17M -31.6% |
$143.45M -24.8% |
$190.65M -20.9% |
$241.17M +244.5% |
$70.00M |
| Cash and Equivalents | $20.03M +18.4% |
$16.91M -30.4% |
$24.29M -10.3% |
$27.06M -84.8% |
$178.39M +493.1% |
$30.08M |
| Long-Term Debt | $18.90M | $0.00 | — | — | — | — |
| Stockholders Equity | $33.21M -55.9% |
$75.35M -36.1% |
$117.99M -28.1% |
$164.17M -25.7% |
$220.98M +274.0% |
-$127.01M -53.8% |
| R&D Expense | $13.60M -6.8% |
$14.60M +13.9% |
$12.82M -0.4% |
$12.87M +31.5% |
$9.78M +49.8% |
$6.53M |
| Operating Income | -$47.39M +5.1% |
-$49.92M +11.7% |
-$56.56M +10.5% |
-$63.22M -33.8% |
-$47.23M -54.7% |
-$30.54M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $7.84M | +3.1% | +7.9% |
| Revenue (ASC 606) | September 30, 2025 | $7.84M | +3.1% | +7.9% |
| Net Income | September 30, 2025 | -$11.51M | -1.6% | +3.0% |
| Diluted EPS | September 30, 2025 | -$0.26 | +0.0% | +3.7% |
| Total Assets | September 30, 2025 | $84.41M | -20.3% | +11.7% |
| Cash and Equivalents | September 30, 2025 | $18.95M | -14.1% | +3.3% |
| Long-Term Debt | September 30, 2025 | $18.83M | — | — |
| Stockholders Equity | September 30, 2025 | $44.33M | -47.5% | -18.7% |
| R&D Expense | September 30, 2025 | $3.53M | -2.2% | +9.3% |
| Operating Income | September 30, 2025 | -$11.37M | +5.5% | +6.4% |
- RAPID MICRO BIOSYSTEMS, INC. reported Total Revenue of $33.59 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed an increase of +19.7% in Total Revenue compared to the prior fiscal year.
- RAPID MICRO BIOSYSTEMS, INC. reported Revenue (ASC 606) of $33.59 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed an increase of +19.7% in Revenue (ASC 606) compared to the prior fiscal year.
- RAPID MICRO BIOSYSTEMS, INC. reported Net Income of -$47.12 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed a decrease of -0.5% in Net Income compared to the prior fiscal year.
- RAPID MICRO BIOSYSTEMS, INC. reported Diluted EPS of $1.05 per share (loss) for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed an increase of +2.8% in Diluted EPS compared to the prior fiscal year.
- RAPID MICRO BIOSYSTEMS, INC. reported Total Assets of $74.85 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed a decrease of -23.8% in Total Assets compared to the prior fiscal year.
- RAPID MICRO BIOSYSTEMS, INC. reported Cash and Equivalents of $20.03 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed an increase of +18.4% in Cash and Equivalents compared to the prior fiscal year.
- RAPID MICRO BIOSYSTEMS, INC. reported Long-Term Debt of $18.90 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. reported Stockholders Equity of $33.21 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed a decrease of -55.9% in Stockholders Equity compared to the prior fiscal year.
- RAPID MICRO BIOSYSTEMS, INC. reported R&D Expense of $13.60 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed a decrease of -6.8% in R&D Expense compared to the prior fiscal year.
- RAPID MICRO BIOSYSTEMS, INC. reported Operating Income of -$47.39 million for fiscal year 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed an increase of +5.1% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: